Stock-Based Compensation (Details) (USD $) | 3 Months Ended | 9 Months Ended |
In Millions, except Share data, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | $38.50 | | $45.50 | | $103.60 | | $103.20 | |
Common Shares Available for Grant | 28,800,000 | | ' | | 28,800,000 | | ' | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | ' | | ' | | ' | | ' | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | 21.2 | | 19.2 | | 44.9 | | 40 | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Unrecognized compensation expense | 127.5 | | ' | | 127.5 | | ' | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | ' | | ' | | '2 years 10 months 24 days | | ' | |
Stock Options and SARs [Member] | ' | | ' | | ' | | ' | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | ' | | ' | | ' | | ' | |
Weighted Average Fair Value of Grants (price per share) | ' | | ' | | $30.77 | | $27.34 | |
Expected Volatility (in hundredths) | ' | | ' | | 35.25% | | 35.86% | |
Risk-Free Interest Rate (in hundredths) | ' | | ' | | 0.95% | | 0.78% | |
Dividend Yield (in hundredths) | ' | | ' | | 0.60% | | 0.40% | |
Expected Life (in years) | ' | | ' | | '5 years 2 months 12 days | | '5 years 6 months | |
Stock Options and SARs Rollforward [Abstract] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (in shares) | ' | | ' | | 10,452,000 | | 12,438,000 | |
Granted (in shares) | ' | | ' | | 2,122,000 | | 2,234,000 | |
Exercised (1) (in shares) | ' | | ' | | -1,351,000 | [1] | -3,648,000 | [1] |
Forfeited (in shares) | ' | | ' | | -226,000 | | -168,000 | |
Outstanding at September 30 (2) (in shares) | 10,997,000 | [2] | 10,856,000 | [2] | 10,997,000 | [2] | 10,856,000 | [2] |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (price per share) | ' | | ' | | $54.43 | | $42.91 | |
Granted (price per share) | ' | | ' | | $101.65 | | $83.66 | |
Exercised (1) (price per share) | ' | | ' | | $44.52 | [1] | $34.52 | [1] |
Forfeited (price per share) | ' | | ' | | $62.95 | | $48.38 | |
Outstanding at September 30 (2) (price per share) | $64.58 | [2] | $54.03 | [2] | $64.58 | [2] | $54.03 | [2] |
Stock Options and SARs Vested or Expected to Vest (in shares) | 10,568,000 | [3] | 10,398,000 | [3] | 10,568,000 | [3] | 10,398,000 | [3] |
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) | $63.92 | [3] | $53.63 | [3] | $63.92 | [3] | $53.63 | [3] |
Stock Options and SARs Exercisable at September 30 (in shares) | 5,573,000 | [4] | 4,982,000 | [4] | 5,573,000 | [4] | 4,982,000 | [4] |
Stock Options and SARs Exercisable at September 30 (price per share) | $49.23 | [4] | $44.03 | [4] | $49.23 | [4] | $44.03 | [4] |
Intrinsic value of stock options/SARs exercised during the period | ' | | ' | | 78 | | 134.2 | |
Aggregate intrinsic value for outstanding stock options and SARs | 384.9 | | 332.3 | | 384.9 | | 332.3 | |
Weighted average remaining contractual life for stock options/SARs outstanding (in years) | ' | | ' | | '4 years 7 months 6 days | | '4 years 9 months 18 days | |
Aggregate intrinsic value of stock options/SARs vested or expected to vest | 376.6 | | 322.5 | | 376.6 | | 322.5 | |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | ' | | ' | | '4 years 6 months | | '4 years 8 months 12 days | |
Aggregate intrinsic value for exercisable units | 277.5 | | 202.4 | | 277.5 | | 202.4 | |
Weighted average remaining contractual life for exercisable options/SARs (in years) | ' | | ' | | '3 years 3 months 18 days | | '3 years 6 months | |
ESPP [Member] | ' | | ' | | ' | | ' | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | ' | | ' | | ' | | ' | |
Weighted Average Fair Value of Grants (price per share) | ' | | ' | | $21.27 | | $15.07 | |
Expected Volatility (in hundredths) | ' | | ' | | 25.12% | | 29.89% | |
Risk-Free Interest Rate (in hundredths) | ' | | ' | | 0.08% | | 0.11% | |
Dividend Yield (in hundredths) | ' | | ' | | 0.50% | | 0.60% | |
Expected Life (in years) | ' | | ' | | '6 months | | '6 months | |
Restricted Stock and Restricted Stock Units [Member] | ' | | ' | | ' | | ' | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Unrecognized compensation expense | 192.5 | | ' | | 192.5 | | ' | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | ' | | ' | | '2 years 7 months 6 days | | ' | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | 13.9 | | 19.2 | | 53.4 | | 55.5 | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (in shares) | ' | | ' | | 7,358,000 | | 7,636,000 | |
Granted (in shares) | ' | | ' | | 1,024,000 | | 1,284,000 | |
Released (in shares) | ' | | ' | | -2,540,000 | [5] | -1,234,000 | [5] |
Forfeited (in shares) | ' | | ' | | -220,000 | | -160,000 | |
Outstanding at September 30 (1) (in shares) | 5,622,000 | [6] | 7,526,000 | [6] | 5,622,000 | [6] | 7,526,000 | [6] |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (price per share) | ' | | ' | | $49.54 | | $45.53 | |
Granted (price per share) | ' | | ' | | $99 | | $75.93 | |
Released (price per share) | ' | | ' | | $37.92 | [5] | $52.89 | [5] |
Forfeited (price per share) | ' | | ' | | $59.36 | | $47.70 | |
Outstanding at September 30 (1) (price per share) | $63.41 | [6] | $49.47 | [6] | $63.41 | [6] | $49.47 | [6] |
Intrinsic value of restricted stock and restricted stock units released during the year | ' | | ' | | 270 | | 89.2 | |
Aggregate intrinsic value of stock and units outstanding | 556.7 | | 637 | | 556.7 | | 637 | |
Performance Units and Performance Stock [Member] | ' | | ' | | ' | | ' | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | ' | | ' | | ' | | ' | |
Weighted Average Fair Value of Grants (price per share) | ' | | ' | | $119.27 | | $100.34 | |
Expected Volatility (in hundredths) | ' | | ' | | 32.18% | | 33.63% | |
Risk-Free Interest Rate (in hundredths) | ' | | ' | | 1.18% | | 0.79% | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | ' | | ' | | ' | | ' | |
Unrecognized compensation expense | 9.4 | | ' | | 9.4 | | ' | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | ' | | ' | | '1 year 10 months 24 days | | ' | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (in shares) | ' | | ' | | 261,000 | | 142,000 | |
Granted (in shares) | ' | | ' | | 72,000 | | 119,000 | |
Released (in shares) | ' | | ' | | 0 | | 0 | |
Forfeited (in shares) | ' | | ' | | 0 | | 0 | |
Outstanding at September 30 (1) (in shares) | 333,000 | [7] | 261,000 | [7] | 333,000 | [7] | 261,000 | [7] |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | ' | | ' | | ' | | ' | |
Outstanding at January 1 (price per share) | ' | | ' | | $82.18 | | $67.05 | |
Granted (price per share) | ' | | ' | | $119.27 | | $100.34 | |
Released (price per share) | ' | | ' | | $0 | | $0 | |
Forfeited (price per share) | ' | | ' | | $0 | | $0 | |
Outstanding at September 30 (1) (price per share) | $90.17 | [7] | $82.18 | [7] | $90.17 | [7] | $82.18 | [7] |
Aggregate intrinsic value of stock and units outstanding | 33 | | 22.1 | | 33 | | 22.1 | |
Performance Units and Performance Stock [Abstract] | ' | | ' | | ' | | ' | |
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost | 3.4 | | 7.1 | | 5.3 | | 7.7 | |
Term Of Zero- Coupon Risk- Free Interest Rate In Years Derived From Treasury Constant Maturities Yield Curve | ' | | ' | | '3 years 3 months 4 days | | ' | |
Lease And Well [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | 9.7 | | 7.2 | | 30.4 | | 25.4 | |
Gathering And Processing Costs [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | 0.4 | | 0.3 | | 0.9 | | 0.9 | |
Exploration Costs [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | 6.7 | | 6.7 | | 20.2 | | 20.6 | |
General And Administrative [Member] | ' | | ' | | ' | | ' | |
Stock based compensation by job function [Line Items] | ' | | ' | | ' | | ' | |
Compensation expense related to the company's stock-based compensation plans | $21.70 | | $31.30 | | $52.10 | | $56.30 | |
|
[1] | (1)The total intrinsic value of stock options/SARs exercised for the nine months ended SeptemberB 30, 2014 and 2013 was $78.0 million and $134.2 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. |
[2] | (2)The total intrinsic value of stock options/SARs outstanding at SeptemberB 30, 2014 and 2013 was $384.9 million and $332.3 million, respectively. At SeptemberB 30, 2014 and 2013, the weighted average remaining contractual life was 4.6 years and 4.8 years, respectively. |
[3] | (3)The total intrinsic value of stock options/SARs vested or expected to vest at SeptemberB 30, 2014 and 2013 was $376.6 million and $322.5 million, respectively. At SeptemberB 30, 2014 and 2013, the weighted average remaining contractual life was 4.5 years and 4.7 years, respectively. |
[4] | (4)The total intrinsic value of stock options/SARs exercisable at SeptemberB 30, 2014 and 2013 was $277.5 million and $202.4 million, respectively. At SeptemberB 30, 2014 and 2013, the weighted average remaining contractual life was 3.3 years and 3.5 years, respectively. |
[5] | (1)The total intrinsic value of restricted stock and restricted stock units released for the nine months ended SeptemberB 30, 2014 and 2013 was $270.0 million and $89.2 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released. |
[6] | (2)The total intrinsic value of restricted stock and restricted stock units outstanding at SeptemberB 30, 2014 and 2013 was $556.7 million and $637.0 million, respectively. |
[7] | (1)The total intrinsic value of performance units and performance stock outstanding at SeptemberB 30, 2014 and 2013 was $33.0 million and $22.1 million, respectively. |